Results 241 to 250 of about 15,636 (296)
Some of the next articles are maybe not open access.
Dermal dendrocytes and photochemotherapy
Virchows Archiv A Pathological Anatomy and Histopathology, 1991We studied the fate of dermal dendrocytes in patients treated with psoralens and ultraviolet light by combining immunohistochemistry and computerized image analysis. Factor-XIIIa-positive dermal dendrocytes were found to be altered in these patients. When compared with controls, dermal dendrocytes were often increased in number and had an uneven size ...
Pierard, Gérald +4 more
openaire +2 more sources
ACS Applied Bio Materials, 2018
Effective treatment of malignant melanoma requires an appropriate combination of therapeutic intervention with long-term prognosis as it often survives by monotherapies. Herein, we report a novel melanoma-targeted theranostic nanoenvelope (MTTNe: ISQ@BSA-
Palasseri T. Sujai +9 more
semanticscholar +1 more source
Effective treatment of malignant melanoma requires an appropriate combination of therapeutic intervention with long-term prognosis as it often survives by monotherapies. Herein, we report a novel melanoma-targeted theranostic nanoenvelope (MTTNe: ISQ@BSA-
Palasseri T. Sujai +9 more
semanticscholar +1 more source
Photochemotherapy: Dermatologic Uses
Southern Medical Journal, 1978Photochemotherapy is a new concept in treating selected skin disease. Psoralens taken orally two hours before high-intensity UVA radiation results in clinical clearing of psoriasis, mycosis fungoides, vitiligo, and atopic eczema. The results of two large cooperative studies in the treatment of psoriasis presented similar results.
openaire +2 more sources
Photochemotherapy Treatment for Psoriasis
Physical Therapy, 1981Psoriasis is a disease resulting from accelerated replication and abnormal maturation of epidermal cells.1 It has a 1 to 2 percent prevalence in the United States.1 Currently, therapy is merely suppressive. Conventional treatment for psoriasis is the Goeckerman technique, involving the use of tar and ultraviolet B (UVB) (290–320 nm).2 Classically ...
D G, Shurr, R L, Zuehlke
openaire +2 more sources
Photochemotherapy of Sézary Syndrome
Dermatology, 1981Photochemotherapy was effectively applied in 4 patients with Sézary syndrome. Clinically, complete clearing of the skin could be achieved by this kind of treatment. Photochemotherapy may be recommended as a useful treatment of less advanced cases for patients with no history of extreme sun sensitivity.
P M, Kövary, P, Frosch, E, Macher
openaire +2 more sources
Phototherapy and Photochemotherapy
1983The beneficial and adverse effects of nonionizing radiation in the treatment of certain skin diseases may involve immunologic mechanisms. The most recent and direct evidence for this comes from studies of the effects of oral psoralen photochemotherapy (psoralen plus UVA radiation, PVA), which show that immune function is affected by this treatment ...
openaire +2 more sources
PHOTOCHEMOTHERAPY OF PSORIASIS
International Journal of Dermatology, 1978ABSTRACT: Orally administered 8‐methoxypsoralen followed by irradiation with longwave ultraviolet light (UVA, 320–400 nm, maximum 365 nm) resulted in 90–100% clearing in 24 of 26 psoriasis patients. Recurrence could be prevented by maintenance treatment. The treatment was tolerated well; no serious side effects were observed.
openaire +2 more sources
Photochemotherapy for Psoriasis
Archives of Dermatology, 1978To the Editor.— The article in the DecemberArchives(113:1667-1670, 1977) by Roenigk and Martin on photochemotherapy of psoriasis was most informative. The authors noted that their patients wore sunglasses that protect against ultraviolet-A (UV-A) for five hours after photochemotherapy is given in the office.
openaire +2 more sources
Dermatology nursing, 1998
Psoralens and sunlight have been used by the Egyptians and Indians for hundreds of years for treating vitiligo. The combination of oral psoralens and artificial ultraviolet A (PUVA) therapy was approved for managing severe psoriasis by the Food and Drug Administration in 1982.
P B, McClelland +3 more
openaire +1 more source
Psoralens and sunlight have been used by the Egyptians and Indians for hundreds of years for treating vitiligo. The combination of oral psoralens and artificial ultraviolet A (PUVA) therapy was approved for managing severe psoriasis by the Food and Drug Administration in 1982.
P B, McClelland +3 more
openaire +1 more source